Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Tianda Pharmaceuticals Ltd. ( (HK:0455) ).
Tianda Pharmaceuticals Ltd. has announced a board meeting scheduled for March 28, 2025, to approve the company’s final results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential returns to shareholders, impacting its market positioning and stakeholder interests.
More about Tianda Pharmaceuticals Ltd.
Tianda Pharmaceuticals Ltd. is a company incorporated in the Cayman Islands with limited liability, operating in the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products and services.
YTD Price Performance: -1.18%
Average Trading Volume: 72,250
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$361.2M
For detailed information about 0455 stock, go to TipRanks’ Stock Analysis page.